BioFlyte, Inc., founded in 2020, is a dynamic player in the Biotechnology and Life Sciences industries, headquartered in the United States. The company operates under the slogan, "BioThreat Security at Scale," and aims to revolutionize protection against biological and low-volatility chemical threats.
BioFlyte is pioneering a new class of fieldable aerosol mass spectrometers, offering a cutting-edge solution for bio-threat detection. This technology positions the company strongly at the intersection of innovation and security, addressing growing global concerns.
The recent $5.40M Series B investment, completed on August 10, 2023, highlights significant confidence in BioFlyte's potential. Key investors include Cottonwood Technology Fund, Scout Ventures, and NM Vintage Fund. This funding is expected to accelerate the commercialization and scaling of BioFlyte's technological solutions, making it a promising venture for future funding considerations.